Sartorius Aktiengesellschaft Cash Flow Conversion Efficiency
Sartorius Aktiengesellschaft cash flow conversion efficiency. Based on the latest financial reports, Sartorius Aktiengesellschaft (SRT3) has a cash flow conversion efficiency ratio of 0.044x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€175.50 Million ≈ $205.18 Million USD) by net assets (€4.00 Billion ≈ $4.67 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Sartorius Aktiengesellschaft (2002–2025)
Cash flow conversion efficiency of Sartorius Aktiengesellschaft from 2002 to 2025. This chart illustrates how Sartorius Aktiengesellschaft's cash flow conversion efficiency has evolved over time, based on yearly financial data. View current stock price of Sartorius Aktiengesellschaft for real-time trading data and today's change.
Sartorius Aktiengesellschaft Cash Flow Conversion Ratio Explained
Sartorius Aktiengesellschaft cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Sartorius Aktiengesellschaft Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Sartorius Aktiengesellschaft ranked by their cash flow conversion efficiency. Also see SRT3 market cap overview for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
ZTO EXPRESS (CAYMAN)
F:ZTOB
|
N/A |
|
Semtech Corporation
NASDAQ:SMTC
|
0.092x |
|
Baxter International Inc
NYSE:BAX
|
0.046x |
|
Azrieli Group Ltd
TA:AZRG
|
0.022x |
|
Jazz Pharmaceuticals plc
F:J7Z
|
0.090x |
|
Industrivarden AB ser. A
ST:INDU-A
|
0.042x |
|
Krung Thai Bank Public Company Limited
F:NVPB
|
0.153x |
|
The Phoenix Holdings Ltd.
TA:PHOE
|
0.285x |
Annual Cash Flow Conversion Efficiency for Sartorius Aktiengesellschaft (2002–2025)
The table below shows the annual cash flow conversion efficiency of Sartorius Aktiengesellschaft from 2002 to 2025. Review Sartorius Aktiengesellschaft (SRT3) free cash flow to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | €3.87 Billion ≈ $4.52 Billion |
€656.00 Million ≈ $766.93 Million |
0.170x | -32.27% |
| 2024-12-31 | €3.90 Billion ≈ $4.56 Billion |
€976.20 Million ≈ $1.14 Billion |
0.250x | -19.10% |
| 2023-12-31 | €2.76 Billion ≈ $3.22 Billion |
€853.60 Million ≈ $997.95 Million |
0.310x | +12.11% |
| 2022-12-31 | €2.66 Billion ≈ $3.11 Billion |
€734.20 Million ≈ $858.36 Million |
0.276x | -45.14% |
| 2021-12-31 | €1.72 Billion ≈ $2.01 Billion |
€865.81 Million ≈ $1.01 Billion |
0.503x | +37.97% |
| 2020-12-31 | €1.40 Billion ≈ $1.64 Billion |
€511.52 Million ≈ $598.03 Million |
0.365x | +4.57% |
| 2019-12-31 | €1.08 Billion ≈ $1.26 Billion |
€377.19 Million ≈ $440.97 Million |
0.349x | +38.87% |
| 2018-12-31 | €973.39 Million ≈ $1.14 Billion |
€244.52 Million ≈ $285.87 Million |
0.251x | -1.89% |
| 2017-12-31 | €806.56 Million ≈ $942.95 Million |
€206.51 Million ≈ $241.43 Million |
0.256x | +10.70% |
| 2016-12-31 | €736.80 Million ≈ $861.40 Million |
€170.42 Million ≈ $199.24 Million |
0.231x | +18.96% |
| 2015-12-31 | €644.75 Million ≈ $753.78 Million |
€125.36 Million ≈ $146.56 Million |
0.194x | -25.48% |
| 2014-12-31 | €497.08 Million ≈ $581.14 Million |
€129.69 Million ≈ $151.62 Million |
0.261x | +13.76% |
| 2013-12-31 | €450.25 Million ≈ $526.39 Million |
€103.26 Million ≈ $120.72 Million |
0.229x | +74.21% |
| 2012-12-31 | €403.82 Million ≈ $472.11 Million |
€53.16 Million ≈ $62.15 Million |
0.132x | -39.03% |
| 2011-12-31 | €366.02 Million ≈ $427.92 Million |
€79.03 Million ≈ $92.40 Million |
0.216x | -26.42% |
| 2010-12-31 | €327.18 Million ≈ $382.51 Million |
€96.01 Million ≈ $112.24 Million |
0.293x | -34.66% |
| 2009-12-31 | €319.25 Million ≈ $373.23 Million |
€143.36 Million ≈ $167.61 Million |
0.449x | +182.53% |
| 2008-12-31 | €333.38 Million ≈ $389.76 Million |
€52.99 Million ≈ $61.95 Million |
0.159x | +60.24% |
| 2007-12-31 | €334.10 Million ≈ $390.60 Million |
€33.14 Million ≈ $38.75 Million |
0.099x | -67.60% |
| 2006-12-31 | €168.93 Million ≈ $197.50 Million |
€51.72 Million ≈ $60.46 Million |
0.306x | +3.56% |
| 2005-12-31 | €148.35 Million ≈ $173.44 Million |
€43.85 Million ≈ $51.27 Million |
0.296x | -20.82% |
| 2004-12-31 | €136.53 Million ≈ $159.62 Million |
€50.97 Million ≈ $59.59 Million |
0.373x | -1.18% |
| 2003-12-31 | €128.93 Million ≈ $150.73 Million |
€48.71 Million ≈ $56.95 Million |
0.378x | +50.29% |
| 2002-12-31 | €133.88 Million ≈ $156.52 Million |
€33.66 Million ≈ $39.35 Million |
0.251x | -- |
About Sartorius Aktiengesellschaft
Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers analytical solutions, such as biolayer interferometry systems, high-throughput screening by cytometry systems, process analytical technology and data analytics, cell selection and retrieval, live-cell imaging and analysis systems, and surface plasmon resonance systems; cell cult… Read more